Ocular Therapeutix (NASDAQ:OCUL) reported its Q4 earnings results on Monday, February 28, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Ocular Therapeutix reported in-line EPS of $-0.23 versus an estimate of $-0.23.
Revenue was up $4.96 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 7.46% increase in the share price the next day.
Here's a look at Ocular Therapeutix's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.26 | -0.21 | -0.21 | |
| EPS Actual | -0.23 | -0.25 | -0.24 | -1.21 |
| Revenue Estimate | 12.45M | 11.60M | 7.64M | 9.76M |
| Revenue Actual | 12.15M | 11.72M | 7.34M | 7.35M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
